midpage
Projects
Sign in to see your projects.
375 F. Supp. 3d 496
S.D. Ill.
2019
Read the full case

Background

  • Omega Healthcare Investors (a REIT) invested in healthcare facility operators; Orianna (New ARK affiliate) was Omega's second-largest operator and fell behind on rent in Q1–Q3 2017.
  • On May 2, 2017, Omega made an undisclosed $18.8 million working‑capital loan to Orianna; Omega issued Q1 guidance and a May 3 press release the following day.
  • Omega repeatedly disclosed Orianna's operational problems across earnings calls and SEC 10‑Q filings in May, July, August, and October 2017; by Q3 Omega placed Orianna on cash‑basis accounting and reduced 2017 guidance.
  • Lead plaintiff Setzer filed a consolidated amended class action asserting §10(b)/Rule 10b‑5 and §20(a) claims, alleging (1) material misstatements in FFO/AFFO caused by loan‑propped rent and (2) a material omission in failing to disclose the loan.
  • Defendants moved to dismiss under Rule 12(b)(6) and the PSLRA; the district court granted dismissal in full, dismissing claims with prejudice.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Were Omega's FFO/AFFO statements materially false because Orianna's rent was funded by Omega's loan? FFO/AFFO were inflated because Orianna used Omega’s loan to pay rent, so reported revenue was misleading. Plaintiffs fail to plead GAAP violation or facts showing that treating those receipts as rent was improper. Dismissed for lack of material falsity — no well‑pleaded accounting theory or facts showing GAAP violation.
Was omission of the working‑capital loan a materially required disclosure? The loan was material given Orianna's significance (a “top‑10” operator) and the loan’s economic impact. The loan was quantitatively immaterial and Omega disclosed Orianna’s problems elsewhere; no duty to disclose the loan. At pleading stage omission could be material (qualitative factors), so materiality adequately alleged as to omission.
Did plaintiffs plead scienter (intent/recklessness) required by the PSLRA? Non‑disclosure, contemporaneous disclosure of a different loan, and the loan's purpose support an inference of recklessness or intent. Allegations show only corporate profit motive and hindsight; disclosures and the loan itself rebut inference of intent; no GAAP breach alleged. Dismissed for failure to plead a strong inference of scienter; opposing, nonculpable inferences were at least as compelling.
Did Omega violate Item 303 (Regulation S‑K) by not disclosing that the May 5 10‑Q’s risk had materialized? Item 303 required disclosure that tenant‑bankruptcy risk had materialized due to the loan covering rent. As of May 5 the risk had not materialized; management’s loan showed it did not believe bankruptcy was reasonably likely. Dismissed: no Item 303 violation because trend/uncertainty was not reasonably likely to come to fruition as of filing.
Are §20(a) control‑person claims viable? Individual executives who spoke to investors should be liable as control persons. Primary §10(b) claim fails, so control‑person claim cannot stand. Dismissed: §20(a) claims fail because no primary securities‑fraud violation was pleaded.

Key Cases Cited

  • Bell Atl. Corp. v. Twombly, 550 U.S. 544 (establishes plausibility standard for complaints)
  • Ashcroft v. Iqbal, 556 U.S. 662 (clarifies pleading standard and inference drawing)
  • Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308 (requires strong inference of scienter at least as compelling as nonculpable inferences)
  • Basic Inc. v. Levinson, 485 U.S. 224 (defines materiality as whether omitted fact would have altered the mix of available information)
  • Ganino v. Citizens Utils. Co., 228 F.3d 154 (elements of §10(b) claim and scienter frameworks)
  • Litwin v. Blackstone Grp., L.P., 634 F.3d 706 (qualitative factors may render quantitatively small items material)
  • Novak v. Kasaks, 216 F.3d 300 (motive and opportunity and particularity in pleading scienter)
  • Kalnit v. Eichler, 264 F.3d 131 (motive must be concrete/personal; circumstantial recklessness standards)
Read the full case

Case Details

Case Name: In re Omega Healthcare Investors, Inc.
Court Name: District Court, S.D. Illinois
Date Published: Mar 25, 2019
Citations: 375 F. Supp. 3d 496; 17 Civ. 8983 (NRB)
Docket Number: 17 Civ. 8983 (NRB)
Court Abbreviation: S.D. Ill.
Log In